Advertisement

Clinical Signs and Electrocardiography

  • Elisabeta Bădilă
Chapter

Abstract

Right ventricular failure is a complex clinical syndrome that can result from any structural or functional cardiovascular disorder that impairs the ability of the right ventricle to fill or to eject blood. The approach to the patient with known or suspected right heart pathology begins with a directed history and targeted physical examination, the scope of which depends on the clinical context at the time of presentation. These exams are augmented by a series of paraclinic tests that help to accurately establish etiology and classify severity. Symptoms of right heart disease are often due to the underlying disease and depend on the severity of the condition. In acute life threatening situations, i.e. acute pulmonary embolism or right ventricular myocardial infarction, the clinical presentation may be dominated by hemodynamic instability even progressing to cardiogenic shock. The clinical signs encountered in patients with chronic right heart pathology are initially due to the development of pulmonary hypertension; afterwards, they are completed by the development of right ventricular hypertrophy and a typical picture of right ventricular failure, dominated by systemic congestion.

The electrocardiogram is a standard part of the initial assessment of every patient with suspected right heart failure and also in previously diagnosed patients presented for a routine examination or for a new decompensation. Right ventricular hypertrophy, right axis deviation, and right bundle-branch block may suggest chronic right ventricular pressure overload. The sensitivity of the ECG for the diagnosis of pulmonary hypertension is poor, whereas the specificity of signs of right ventricular hypertrophy is high. Electrocardiographic changes do not correlate with disease severity or prognosis.

Keywords

Right ventricular failure Right ventricular hypertrophy Pulmonary hypertension Systemic congestion Electrocardiography in right heart disease 

References

  1. 1.
    Weitzenblum E, Chaouat A. Cor pulmonale. Chron Respir Dis. 2009;6(3):177–85.CrossRefPubMedGoogle Scholar
  2. 2.
    Haddad F, Doyle R, Murphy DJ, Hunt SA. Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure. Circulation. 2008;117(13):1717–31.CrossRefGoogle Scholar
  3. 3.
    Matthews JC, McLaughlin V. Acute right ventricular failure in the setting of acute pulmonary embolism or chronic pulmonary hypertension: a detailed review of the pathophysiology, diagnosis, and management. Curr Cardiol Rev. 2008;4(1):49–59. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2774585&tool=pmcentrez&rendertype=abstract.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Watts JA, Marchick MR, Kline JA. Right ventricular heart failure from pulmonary embolism: key distinctions from chronic pulmonary hypertension. J Card Fail. 2010;16(3):250–9.  https://doi.org/10.1016/j.cardfail.2009.11.008.CrossRefPubMedGoogle Scholar
  5. 5.
    Dumitru I, Baker MM, Ooi HH. Heart failure clinical presentation. eMedicine; 2014 from: http://emedicine.medscape.com/article/163062-clinical.
  6. 6.
    Mesquita SM, Castro CR, Ikari NM, Oliveira SA, Lopes AA. Likelihood of left main coronary artery compression based on pulmonary trunk diameter in patients with pulmonary hypertension. Am J Med. 2004;116:369.CrossRefPubMedGoogle Scholar
  7. 7.
    Safi M, Eslami V, Shabestari AA, Saadat H, Namazi MH, Vakili H, et al. Extrinsic compression of left main coronary artery by the pulmonary trunk secondary to pulmonary hypertension documented using 64-slice multidetector computed tomography coronary angiography. Clin Cardiol. 2009;32(8):426.CrossRefPubMedGoogle Scholar
  8. 8.
    Tongers J, et al. Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension. Am Heart J. 2017;153(1):127–32.  https://doi.org/10.1016/j.ahj.2006.09.008.CrossRefGoogle Scholar
  9. 9.
    Rajdev A, Garan H, Biviano A. Arrhythmias in pulmonary arterial hypertension. Prog Cardiovasc Dis. 2012;55(2):180–6.  https://doi.org/10.1016/j.pcad. 2012.06.002. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832144/.CrossRefPubMedGoogle Scholar
  10. 10.
    Arena V, De Giorgio F, Abbate A, Capelli A, De Mercurio D, Carbone A. Fatal pulmonary arterial dissection and sudden death as initial manifestation of primary pulmonary hypertension: a case report. Cardiovasc Pathol. 2004;13:230.CrossRefPubMedGoogle Scholar
  11. 11.
    Mann DL, Zipes DP, Libby P, Bonow RO. Braunwald’s heart disease: a textbook of cardiovascular medicine. 10th ed. Philadelphia: Saunders; 2014.Google Scholar
  12. 12.
    Rubin LJ, Hopkins W. Clinical features and diagnosis of pulmonary hypertension in adults. Uptodate Topic 8249 Version 22.0; 2017.Google Scholar
  13. 13.
    Tapson VF. Acute pulmonary embolism. Cardiol Clin. 2004;22:353.CrossRefPubMedGoogle Scholar
  14. 14.
    Applefeld MM. The jugular venous pressure and pulse contour. In: Hurst JW, Walker HK, Hall WD, editors. Clinical methods: the history, physical, and laboratory examinations. Boston: Butterworths; 1990.Google Scholar
  15. 15.
    Shapira Y, Porter A, Wurzel M. Evaluation of tricuspid regurgitation severity: echocardiographic and clinical correlation. J Am Soc Echocardiogr. 1998;11(6):652.CrossRefPubMedGoogle Scholar
  16. 16.
    Wiese J. The abdominojugular reflux sign. Am J Med. 2000;109(1):59.CrossRefPubMedGoogle Scholar
  17. 17.
    Ambrosy AP, et al. The predictive value of transaminases at admission in patients hospitalized for heart failure: findings from the RO-AHFS registry. Eur Heart J Acute Cardiovasc Care. 2013;2(2):99–108. http://journals.sagepub.com/doi/10.1177/2048872612474906.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Dorobantu M, Badila E. Insuficienta Cardiaca Cronica. In: Dorobantu M, editor. Compendiu de Boli Cardiovasculare. Bucharest: Editura Universitara Carol Davila; 2010.Google Scholar
  19. 19.
    Farber MO, et al. Hormonal abnormalities affecting sodium and water balance in acute respiratory failure due to chronic obstructive lung disease. Chest. 1984;85(1):49–54.  https://doi.org/10.1378/chest.85.1.49.CrossRefPubMedGoogle Scholar
  20. 20.
    Porcel JM. Pleural effusions from congestive heart failure. Semin Respir Crit Care Med. 2010;31(6):689.CrossRefPubMedGoogle Scholar
  21. 21.
    Han CH, Choi JE, Chung JH. Clinical utility of pleural fluid NT-pro brain natriuretic peptide (NT-proBNP) in patients with pleural effusions. Intern Med. 2008;47(19):1669–74. https://www.jstage.jst.go.jp/article/internalmedicine/47/19/47_19_1669/_pdf.CrossRefPubMedGoogle Scholar
  22. 22.
    Kopcinovic LM, Culej J. Pleural, peritoneal and pericardial effusions – a biochemical approach. Biochem Med. 2014;24(1):123–37. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936968/.CrossRefGoogle Scholar
  23. 23.
    Natanzon A, Kronzon I. Pericardial and pleural effusions in congestive heart failure. Anatomical, pathophysiologic, and clinical considerations. Am J Med Sci. 2009;338(3):211–6.  https://doi.org/10.1097/MAJ.0b013 e3181a3936f.CrossRefPubMedGoogle Scholar
  24. 24.
    Otto CM. Etiology, clinical features, and evaluation of tricuspid regurgitation. UpToDate Topic 8119 Version 10.0; 2017.Google Scholar
  25. 25.
    Fukuda S, Gillinov AM, Song JM, Daimon M, Kongsaerepong V, Thomas JD, Shiota T. Echocardiographic insights into atrial and ventricular mechanisms of functional tricuspid regurgitation. Am Heart J. 2006;152:1208.CrossRefPubMedGoogle Scholar
  26. 26.
    Chockalingam A, et al. Right ventricular myocardial infarction: presentation and acute outcomes. Angiology. 2005;56(4):371–6.  https://doi.org/10.1177/000331970505600 402.CrossRefPubMedGoogle Scholar
  27. 27.
    Silverman BD, Carabajal NR, Chorches MA, Taranto AI. Tricuspid regurgitation and acute myocardial infarction. Arch Intern Med. 1982;142(7):1394–5.  https://doi.org/10.1001/archinte.1982.00340200164031.CrossRefPubMedGoogle Scholar
  28. 28.
    van Lingen R, Warshow U, Dalton HR, Hussaini SH. Jaundice as a presentation of heart failure. J R Soc Med. 2005;98(8):357–9. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1181835/.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Feldt RH, et al. Protein-losing enteropathy after the Fontan operation. J Thorac Cardiovasc Surg. 1996;112(3):672–80.  https://doi.org/10.1016/S0022-5223(96)70051-X.CrossRefPubMedGoogle Scholar
  30. 30.
    Ahearn GS, Tapson VF, Rebeiz A, Greenfield JC Jr. Electrocardiography to define clinical status in primary pulmonary hypertension and pulmonary arterial hypertension secondary to collagen vascular disease. Chest. 2002;122:524.CrossRefPubMedGoogle Scholar
  31. 31.
    Bossone E, Paciocco G, Iarussi D, Agretto A, Iacono A, Gillespie BW, et al. The prognostic role of the ECG in primary pulmonary hypertension. Chest. 2002;121:513.CrossRefPubMedGoogle Scholar
  32. 32.
    Oswald-Mammosser M, Oswald T, Nyankiye E, Dickele MC, Grange D, Weitzenblum E. Non-invasive diagnosis of pulmonary hypertension in chronic obstructive pulmonary disease. Comparison of ECG, radiological measurements, echocardiography and myocardial scintigraphy. Eur J Respir Dis. 1987;71:419.PubMedGoogle Scholar
  33. 33.
    Surawicz B, Knilans T. Chou’s electrocardiography in clinical practice. 6th ed. Philadelphia: Saunders; 2008.Google Scholar
  34. 34.
    Hancock EW, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram. Part V: electrocardiogram changes associated with cardiac chamber hypertrophy a scientific statement from the american heart association electrocardiography. J Am Coll Cardiol. 2009;53(11):992–1002.  https://doi.org/10.1016/j.jacc.2008.12.015.CrossRefPubMedGoogle Scholar
  35. 35.
    Gross D. Contributions to the functional morphology of the P wave. Am Heart J. 1961;61:436.CrossRefPubMedGoogle Scholar
  36. 36.
    Murphy ML, et al. Reevaluation of electrocardiographic criteria for left, right and combined cardiac ventricular hypertrophy. Am J Cardiol. 1984;53(8):1140–7.  https://doi.org/10.1016/0002-9149(84)90651-9.CrossRefPubMedGoogle Scholar
  37. 37.
    Goldberger AL. Myocardial infarction: electrocardiographic differential diagnosis. 4th ed. St. Louis: Mosby-Year Book; 1991.Google Scholar
  38. 38.
    Chia BL, Tan HC, Lim YT. Right sided chest lead electrocardiographic abnormalities in acute pulmonary embolism. Int J Cardiol. 1997;61:43.CrossRefPubMedGoogle Scholar
  39. 39.
    Ferrari E, et al. The ECG in pulmonary embolism: predictive value of negative t waves in precordial leads - 80 case reports. Chest. 1997;111(3):537–43.  https://doi.org/10.1378/chest.111.3.537.CrossRefPubMedGoogle Scholar
  40. 40.
    Zehender M, et al. Right ventricular infarction as an independent predictor of prognosis after acute inferior myocardial infarction. N Engl J Med. 1993;328(14):981–8.  https://doi.org/10.1056/NEJM199304083281401.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Nasir K, et al. Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity. Circulation. 2004;110(12):1527 LP–1534. http://circ.ahajournals.org/content/110/12/1527.abstract.CrossRefGoogle Scholar
  42. 42.
    Perez Diez D, Brugada J. Diagnosis and management of arrhythmogenic right ventricular dysplasia. Eur J Cardiol Pract. 2008;7(6)Google Scholar
  43. 43.
    Zhang L, Liu L, Kowey PR, Fontaine GH. The electrocardiographic manifestations of arrhythmogenic right ventricular dysplasia. Curr Cardiol Rev. 2014;10(3):237–45. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4040875/.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Chu AF, Zado E, Marchlinski FE. Atrial arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and ventricular tachycardia. Am J Cardiol. 2010;106(5):720–2.  https://doi.org/10.1016/j.amjcard.2010.04.031.CrossRefPubMedGoogle Scholar
  45. 45.
    Incalzi RA, Fuso L, De Rosa M, Di Napoli A, Basso S, Pagliari G, Pistelli BT. Electrocardiographic signs of chronic cor pulmonale: a negative prognostic finding in chronic obstructive pulmonary disease. Circulation. 1999;99:1600–5.  https://doi.org/10.1161/01.CIR.99.12.1600.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Elisabeta Bădilă
    • 1
    • 2
  1. 1.“Carol Davila” University of Medicine and PharmacyBucharestRomania
  2. 2.Internal Medicine DepartmentClinical Emergency Hospital BucharestBucharestRomania

Personalised recommendations